FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993227487> ?p ?o ?g. }

• W1993227487 endingPage "201.e8" @default.
• W1993227487 startingPage "201.e1" @default.
• W1993227487 abstract "Obesity is associated with an increased risk of high-grade prostate cancer (PCa). The effect of body mass index (BMI) as a predictor of progression in men with low-risk PCa has been only poorly assessed. In this study, we evaluated the association of BMI with progression in patients with low-risk PCa who met the inclusion criteria for the active surveillance (AS) protocol. We assessed 311 patients who underwent radical prostatectomy and were eligible for AS according to the following criteria: clinical stage T2a or less, prostate-specific antigen level<10 ng/ml, 2 or fewer cores involved with cancer, Gleason score ≤6 grade, and prostate-specific antigen density<0.2 ng/ml/cc. Reclassification was defined as upstaged (pathological stage>pT2) and upgraded (Gleason score ≥7; primary Gleason pattern 4) disease. Seminal vesicle invasion, positive lymph nodes, and tumor volume≥0.5 ml were also recorded. We found that high BMI was significantly associated with upgrading, upstaging, and seminal vesicle invasion, whereas it was not associated with positive lymph nodes or large tumor volume. At multivariate analysis, 1 unit increase of BMI significantly increased the risk of upgrading, upstaging, seminal vesicle invasion, and any outcome by 21%, 23%, 27%, and 20%, respectively. The differences between areas under the receiver operating characteristics curves comparing models with and without BMI were statistically significant for upgrading (P = 0.0002), upstaging (P = 0.0007), and any outcome (P = 0.0001). BMI should be a selection criterion for inclusion of patients with low-risk PCa in AS programs. Our results support the idea that obesity is associated with worse prognosis and suggest that a close AS program is an appropriate treatment option for obese subjects." @default.
• W1993227487 created "2016-06-24" @default.
• W1993227487 creator A5001805404 @default.
• W1993227487 creator A5004341642 @default.
• W1993227487 creator A5010586870 @default.
• W1993227487 creator A5013771798 @default.
• W1993227487 creator A5014614796 @default.
• W1993227487 creator A5014890754 @default.
• W1993227487 creator A5027115920 @default.
• W1993227487 creator A5027197519 @default.
• W1993227487 creator A5030522000 @default.
• W1993227487 creator A5043819658 @default.
• W1993227487 creator A5044720061 @default.
• W1993227487 creator A5056612070 @default.
• W1993227487 creator A5057612328 @default.
• W1993227487 creator A5070965901 @default.
• W1993227487 creator A5086324393 @default.
• W1993227487 date "2015-05-01" @default.
• W1993227487 modified "2023-10-10" @default.
• W1993227487 title "Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance" @default.
• W1993227487 cites W1980287224 @default.
• W1993227487 cites W1983175932 @default.
• W1993227487 cites W2003295161 @default.
• W1993227487 cites W2012603255 @default.
• W1993227487 cites W2027142966 @default.
• W1993227487 cites W2034651750 @default.
• W1993227487 cites W2038289366 @default.
• W1993227487 cites W2040604014 @default.
• W1993227487 cites W2047878232 @default.
• W1993227487 cites W2055888354 @default.
• W1993227487 cites W2068748474 @default.
• W1993227487 cites W2072135371 @default.
• W1993227487 cites W2077778575 @default.
• W1993227487 cites W2083043726 @default.
• W1993227487 cites W2088852716 @default.
• W1993227487 cites W2095972575 @default.
• W1993227487 cites W2119302852 @default.
• W1993227487 cites W2125729266 @default.
• W1993227487 cites W2139411934 @default.
• W1993227487 cites W2141662760 @default.
• W1993227487 cites W2145567935 @default.
• W1993227487 cites W2153383900 @default.
• W1993227487 cites W2157996158 @default.
• W1993227487 cites W2171715173 @default.
• W1993227487 doi "https://doi.org/10.1016/j.urolonc.2015.02.004" @default.
• W1993227487 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25791753" @default.
• W1993227487 hasPublicationYear "2015" @default.
• W1993227487 type Work @default.
• W1993227487 sameAs 1993227487 @default.
• W1993227487 citedByCount "51" @default.
• W1993227487 countsByYear W19932274872016 @default.
• W1993227487 countsByYear W19932274872017 @default.
• W1993227487 countsByYear W19932274872018 @default.
• W1993227487 countsByYear W19932274872019 @default.
• W1993227487 countsByYear W19932274872020 @default.
• W1993227487 countsByYear W19932274872021 @default.
• W1993227487 countsByYear W19932274872022 @default.
• W1993227487 countsByYear W19932274872023 @default.
• W1993227487 crossrefType "journal-article" @default.
• W1993227487 hasAuthorship W1993227487A5001805404 @default.
• W1993227487 hasAuthorship W1993227487A5004341642 @default.
• W1993227487 hasAuthorship W1993227487A5010586870 @default.
• W1993227487 hasAuthorship W1993227487A5013771798 @default.
• W1993227487 hasAuthorship W1993227487A5014614796 @default.
• W1993227487 hasAuthorship W1993227487A5014890754 @default.
• W1993227487 hasAuthorship W1993227487A5027115920 @default.
• W1993227487 hasAuthorship W1993227487A5027197519 @default.
• W1993227487 hasAuthorship W1993227487A5030522000 @default.
• W1993227487 hasAuthorship W1993227487A5043819658 @default.
• W1993227487 hasAuthorship W1993227487A5044720061 @default.
• W1993227487 hasAuthorship W1993227487A5056612070 @default.
• W1993227487 hasAuthorship W1993227487A5057612328 @default.
• W1993227487 hasAuthorship W1993227487A5070965901 @default.
• W1993227487 hasAuthorship W1993227487A5086324393 @default.
• W1993227487 hasConcept C121608353 @default.
• W1993227487 hasConcept C126322002 @default.
• W1993227487 hasConcept C126894567 @default.
• W1993227487 hasConcept C143998085 @default.
• W1993227487 hasConcept C146357865 @default.
• W1993227487 hasConcept C151730666 @default.
• W1993227487 hasConcept C2776235491 @default.
• W1993227487 hasConcept C2779466945 @default.
• W1993227487 hasConcept C2780192828 @default.
• W1993227487 hasConcept C2780221984 @default.
• W1993227487 hasConcept C2781406297 @default.
• W1993227487 hasConcept C38180746 @default.
• W1993227487 hasConcept C71924100 @default.
• W1993227487 hasConcept C86803240 @default.
• W1993227487 hasConceptScore W1993227487C121608353 @default.
• W1993227487 hasConceptScore W1993227487C126322002 @default.
• W1993227487 hasConceptScore W1993227487C126894567 @default.
• W1993227487 hasConceptScore W1993227487C143998085 @default.
• W1993227487 hasConceptScore W1993227487C146357865 @default.
• W1993227487 hasConceptScore W1993227487C151730666 @default.
• W1993227487 hasConceptScore W1993227487C2776235491 @default.
• W1993227487 hasConceptScore W1993227487C2779466945 @default.
• W1993227487 hasConceptScore W1993227487C2780192828 @default.
• W1993227487 hasConceptScore W1993227487C2780221984 @default.

• next